Evaluating blood‐based biomarkers for Alzheimer's disease diagnosis across ethnic groups: a systematic review
Blood-based biomarkers for AD are likely to vary in their absolute concentrations and diagnostic performance across ethnoracial groups. High quality studies with harmonised exposures and outcomes are required to provide evidence about how this issue should influence clinical implementation and interpretation of blood-based biomarkers in diverse real-world settings.
Authors
- Claudia Cooper (ORCID: https://orcid.org/0000-0002-2777-7616)
- Rifah Anjum
- Ashvini Keshavan (ORCID: https://orcid.org/0000-0003-1043-5721)
- Charles R. Marshall (ORCID: https://orcid.org/0000-0002-8227-2354)
- Natalia Chemas
Institutions
- Queen Mary University of London (GB)
- UK Dementia Research Institute (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_097986
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00